ID
39229
Beschrijving
Study ID: 111569 Clinical Study ID: 111569 Study Title: A fixed dose, dose-response study for ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01494532 Sponsor: GlaxoSmithKline Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Ropinirole, placebo Study Indication: Parkinson's Disease
Trefwoorden
Versies (7)
- 11-12-19 11-12-19 -
- 11-12-19 11-12-19 -
- 11-12-19 11-12-19 -
- 11-12-19 11-12-19 -
- 16-12-19 16-12-19 -
- 09-01-20 09-01-20 -
- 09-01-20 09-01-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
11 december 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease
Visit 4; Visit 6 - Pregnancy
- StudyEvent: ODM
Beschrijving
Pregnancy
Alias
- UMLS CUI-1
- C0032961
Beschrijving
Did a female partner of a male subject become pregnant during the study?
Datatype
boolean
Alias
- UMLS CUI [1]
- C0919624
Beschrijving
Did the subject become pregnant during the study?
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
Similar models
Visit 4; Visit 6 - Pregnancy
- StudyEvent: ODM